Study #2022-0117
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
MD Anderson Study Status
Enrolling
Treatment Agent
Naproxen, Aspirin
Description
To learn about the effects of naproxen and aspirin on the normal colon in people with Lynch Syndrome.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
T Cells, Colorectal Cancer, Lynch Syndrome
Study phase:
Phase II
Physician name:
Eduardo Vilar Sanchez
Department:
Clinical Cancer Prevention
For general questions about clinical trials:
1-877-582-0066
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.